Amin, Manik
Minton, Susan E.
LoRusso, Patricia M.
Krishnamurthi, Smitha S.
Pickett, Cheryl A.
Lunceford, Jared
Hille, Darcy
Mauro, David
Stein, Mark N.
Wang-Gillam, Andrea
Trull, Lauren
Lockhart, A. Craig
Article History
Received: 17 September 2015
Accepted: 8 November 2015
First Online: 1 December 2015
Ethical standards
: The research complies with the current laws of the United States.
: Funding for this study was provided by Merck & Co., Inc., Kenilworth, NJ, USA.
: JL, DH, DM are current or former employees of Merck & Co., Inc., Kenilworth, NJ, USA and may hold stock/stock options in the company. CP was an employee of Merck & Co., Inc. at the time of the study and held stock in the company; she is currently an employee of Amgen and holds stock in the company. SSK has received funding for this study from Merck & Co., Inc. AW-G has received advisory board payments from Merrimack and Pfizer and study funding from Takeda. MA, SEM, PML, MNS, ACL and LT have no conflicts of interest to disclose.
: All authors are responsible for the work described in this manuscript. All authors were involved in at least one of the following: [conception, design, acquisition, analysis, statistical analysis, interpretation of data] and [drafting the manuscript and/or revising it for important intellectual content]. All authors provided final approval of the version to be published.
: This study was funded by Merck & Co., Inc., Kenilworth, New Jersey, USA.